Agios Pharmaceuticals Inc.
AGIO | NASDAQ
$33.95
+$0.88 (+2.66%)
At close: Sep 21, 2026, 4:00 PM ET
$33.96
+$0.01 (+0.03%)
Pre-market:
Sep 22, 2026, 8:33 AM ET
Market Data
Market Cap $2.03B
Enterprise Value $1.44B
Beta 0.60
Average Volume 1.08M
Shares Outstanding (Diluted) 59.49M
Shares Change YoY 2.69%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US00847X1046
Price Performance
Price Change 1M 2.1%
Price Change 3M -4.6%
Price Change 6M 14.7%
Price Change YTD 24.9%
Price Change 1Y -11.1%
Price Change 3Y 38.4%
Price Change 5Y -28.6%
1M CAGR (ann.) 5.2%
1Y CAGR (ann.) -10.5%
5Y CAGR (ann.) -5.8%
All-Time CAGR 0.6%
Valuation
PE Ratio -4.84
Forward PE N/A
PEG Ratio 0.03
Forward PEG 0.14
PS Ratio 20.61
Forward PS 5.80
PB Ratio 1.98
P/FCF Ratio -5.55
P/Adj. FCF Ratio -4.79
P/OCF Ratio -5.60
EV/Sales 14.65
EV/EBIT -3.41
EV/EBITDA -3.46
EV/FCF -3.94
Earnings Yield -20.6%
FCF Yield -18.0%
Adj. FCF Yield -20.9%
Financial Health
Net Cash $617.58M
Total Debt $31.17M
Cash & Short-Term Investments $617.58M
Total Assets $1.11B
Current Ratio 10.22
Quick Ratio 9.79
Debt / Equity Ratio 0.03
Debt / EBITDA -0.07
Debt / FCF -0.09
OCF / Debt -11.57
Interest Coverage 0.00
Altman Z-Score 13.33
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 87.9%
Operating Profit Margin -466.8%
EBITDA Margin -423.8%
Net Profit Margin -418.2%
FCF Margin -371.4%
Adj. FCF Margin -430.4%
SBC / Revenue 59.0%
SBC Impact (per share) -15.9%
Returns
Return on Assets -37.1%
Return on Equity -35.7%
Return on Invested Capital -43.3%
Return on Capital Employed -44.2%
Return on Tangible Assets -37.1%
Historical Growth (CAGR)
Revenue CAGR 3Y 69.6%
Revenue CAGR 5Y 4.5%
Revenue CAGR 10Y 7.0%
EPS CAGR 3Y -31.1%
EPS CAGR 5Y 55.8%
EPS CAGR 10Y 19.1%
FCF CAGR 3Y -8.0%
FCF CAGR 5Y -4.0%
FCF CAGR 10Y -2.4%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 29
EPS Growth Next 3Y 31.5%
Revenue Growth Next 3Y 88.0%
Earnings Date Oct 28, 2026
EPS Estimate (next Q) -$1.21
EPS Growth Est (next Q) -31.8%
Revenue Est (next Q) $53.8M
Revenue Growth Est (next Q) 317.7%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $42.67
Price Target Upside 25.7%
Cash Flow
Operating Cash Flow $-360.6M
Free Cash Flow $-365.25M
Adj. Free Cash Flow $-423.24M
FCF Per Share -$6.14
OCF Per Share -$6.06
OCF/S Ratio -366.7%
Income Statement
Revenue $98.34M
Gross Profit $86.46M
Operating Income $-459.02M
EBITDA $-416.8M
Net Income $-411.29M
EPS (Diluted) -$7.01
Revenue / Employee $182.11K
Profit / Employee $-761.64K
Employees 540
Add to Watchlist
Select watchlists to add or remove AGIO